Nūmi (formerly MUMilk) is a French cell-cultured human breast milk startup.
It develops human breast milk from cell-cultured mammary glands and plans on producing as many breast milk constituents (from over 1,500) as possible, including different proteins. The startup plans to commercialize its products in the US, Europe, and Asia and is seeking regulatory approvals.
Funding and financials
In November 2023 , the company secured EUR 3 million (~USD 3.2 million) in pre-seed funding backed by Heartcore Capital, HCVC, Financière Saint-James, Kima Ventures, and Kost Capital. The funding was earmarked for expanding Nūmi's scientific team and R&D efforts.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.